Downclassification Of Six Cardiovascular Devices To Class II Delayed
This article was originally published in The Gray Sheet
Executive Summary
FDA is postponing the downclassification from Class III to Class II of six cardiovascular devices pending receipt of public comments on guidance documents intended to serve as special controls for the devices.